▁Prem 10.375
ature 5.09375
▁men 13.0390625
op 12.7265625
ause 5.6640625
, 5.02734375
▁ob 7.48828125
es 5.94140625
ity 2.59765625
, 1.66015625
▁and 3.095703125
▁a 6.70703125
▁pre 5.36328125
dis 1.822265625
position 2.087890625
▁to 3.7421875
▁breast 10.5078125
▁cancer 8.5234375
▁present 9.234375
▁a 4.9921875
▁unique 7.4453125
▁set 7.1953125
▁of 1.0751953125
▁challeng 8.890625
es 0.290771484375
▁when 7.59375
▁dec 8.1328125
iding 3.17578125
▁on 3.98828125
▁a 2.001953125
▁treatment 8.546875
▁plan 6.26953125
▁for 2.146484375
▁middle 9.40625
- 3.37890625
aged 4.73828125
▁women 2.654296875
. 2.703125
▁Two 7.49609375
▁potential 8.484375
▁options 6.6171875
▁for 1.6142578125
▁sympt 10.6171875
om 0.3251953125
▁relief 4.5234375
▁are 1.4140625
▁Met 9.96875
op 1.9130859375
rol 0.136474609375
ol 0.0745849609375
▁and 1.546875
▁Nor 6.08984375
vas 0.9228515625
c 0.0165557861328125
. 0.6103515625
▁However 4.95703125
, 0.18017578125
▁it 3.076171875
▁is 1.0
▁cru 4.61328125
cial 0.0135345458984375
▁to 0.53759765625
▁evaluate 5.4453125
▁the 1.04296875
▁potential 3.537109375
▁ris 2.109375
ks 0.003078460693359375
▁and 0.66064453125
▁benefits 0.72607421875
▁of 0.413330078125
▁each 2.068359375
▁medic 1.7626953125
ation 0.0921630859375
▁in 3.150390625
▁this 4.26953125
▁specific 5.44140625
▁context 3.07421875
, 2.306640625
▁as 2.228515625
▁well 1.107421875
▁as 0.0323486328125
▁consider 3.90625
▁how 4.796875
▁di 7.734375
et 0.79296875
▁and 1.30859375
▁sm 7.21875
oking 0.0078125
▁factor 6.30078125
▁into 0.404296875
▁the 0.70166015625
▁overall 3.376953125
▁treatment 2.525390625
▁plan 0.6943359375
. 0.2396240234375
<0x0A> 1.6376953125
Met 3.513671875
op 0.3173828125
rol 0.006816864013671875
ol 0.022857666015625
▁and 2.263671875
▁Nor 0.37353515625
vas 0.01019287109375
c 0.0030670166015625
▁are 2.185546875
▁both 3.0859375
▁commonly 6.625
▁pres 0.5166015625
cribed 0.006999969482421875
▁medic 0.8681640625
ations 0.41748046875
▁that 2.283203125
▁differ 5.9375
▁in 0.296875
▁their 1.400390625
▁mechan 5.4765625
isms 0.0236053466796875
▁of 0.043731689453125
▁action 0.08648681640625
▁and 1.876953125
▁potential 2.439453125
▁side 0.9892578125
▁effects 0.051910400390625
. 0.23388671875
▁Met 1.5
op 0.0863037109375
rol 0.00473785400390625
ol 0.0011644363403320312
▁is 0.63427734375
▁a 0.96630859375
▁beta 1.4443359375
- 0.64990234375
block 0.12646484375
er 0.1357421875
, 1.7529296875
▁primarily 8.953125
▁used 0.480712890625
▁to 0.350341796875
▁manage 4.43359375
▁hy 1.5947265625
pert 0.00042700767517089844
ension 0.0106201171875
▁and 1.4150390625
▁card 3.9765625
i 0.97314453125
ov 0.001556396484375
asc 0.0006556510925292969
ular 1.0967254638671875e-05
▁conditions 2.333984375
. 0.63671875
▁As 5.9296875
▁a 0.80712890625
▁beta 3.8125
- 0.07244873046875
block 0.01446533203125
er 0.017669677734375
, 0.061614990234375
▁it 1.3115234375
▁reduces 2.109375
▁heart 2.671875
▁rate 0.10821533203125
▁and 0.4951171875
▁blood 0.82861328125
▁pressure 0.036895751953125
. 1.080078125
▁On 3.5390625
▁the 0.05096435546875
▁other 0.08721923828125
▁hand 0.01186370849609375
, 0.00543212890625
▁Nor 0.2197265625
vas 0.00614166259765625
c 0.0006613731384277344
▁is 0.16357421875
▁a 0.49462890625
▁calci 0.89111328125
um 8.511543273925781e-05
▁channel 0.18115234375
▁block 0.03045654296875
er 0.00496673583984375
▁that 2.123046875
▁dil 3.693359375
ates 0.0027484893798828125
▁blood 0.607421875
▁vessels 0.0135650634765625
, 1.7900390625
▁primarily 3.39453125
▁used 0.6513671875
▁to 0.0810546875
▁treat 0.305908203125
▁hy 0.85693359375
pert 8.594989776611328e-05
ension 0.0113983154296875
▁and 0.6689453125
▁ang 2.90234375
ina 0.0164794921875
. 0.56884765625
<0x0A> 1.3212890625
When 5.015625
▁it 3.904296875
▁comes 0.035888671875
▁to 0.021881103515625
▁the 3.27734375
▁ris 5.296875
ks 0.1231689453125
▁of 1.14453125
▁using 3.826171875
▁Met 2.58203125
op 0.051239013671875
rol 0.0017194747924804688
ol 0.0027294158935546875
▁instead 6.953125
▁of 0.04913330078125
▁Nor 0.287353515625
vas 0.0029392242431640625
c 0.00042819976806640625
▁for 3.533203125
▁tre 1.6923828125
ating 0.0006151199340820312
▁the 4.15234375
▁sympt 1.990234375
oms 0.0450439453125
▁of 0.0697021484375
▁prem 7.1015625
ature 0.038482666015625
▁men 2.732421875
op 0.01241302490234375
ause 0.0034122467041015625
▁in 5.09375
▁middle 3.068359375
- 0.453857421875
aged 0.032989501953125
▁women 0.06243896484375
▁with 4.46484375
▁ob 5.6328125
es 0.0283660888671875
ity 0.0036640167236328125
▁and 2.57421875
▁a 2.693359375
▁pre 3.02734375
dis 0.0253448486328125
position 0.007778167724609375
▁to 0.5498046875
▁breast 1.1640625
▁cancer 0.0426025390625
, 0.1890869140625
▁several 6.4921875
▁factors 2.494140625
▁need 3.373046875
▁to 0.022186279296875
▁be 0.01192474365234375
▁considered 0.4853515625
. 0.634765625
▁First 2.546875
ly 2.05078125
, 0.01111602783203125
▁Met 0.7333984375
op 0.0206451416015625
rol 0.0021152496337890625
ol 0.0010900497436523438
' 5.28515625
s 0.02142333984375
▁beta 1.765625
- 0.1527099609375
block 0.016815185546875
ing 0.58935546875
▁effects 2.587890625
▁may 2.029296875
▁lead 3.390625
▁to 0.0162811279296875
▁decre 4.328125
ased 0.0645751953125
▁card 3.587890625
iac 0.369140625
▁output 0.859375
, 0.96630859375
▁particularly 4.4296875
▁in 0.69970703125
▁individuals 5.18359375
▁with 0.29150390625
▁underlying 5.109375
▁card 1.6005859375
i 0.7177734375
ov 0.00901031494140625
asc 0.0003571510314941406
ular 1.9550323486328125e-05
▁conditions 2.56640625
. 0.6181640625
▁Additionally 2.849609375
, 0.0033397674560546875
▁beta 6.5078125
- 0.057159423828125
block 0.0341796875
ers 0.2401123046875
▁have 2.919921875
▁been 0.67822265625
▁associated 1.3310546875
▁with 0.00412750244140625
▁weight 4.703125
▁gain 0.12255859375
, 1.2080078125
▁which 2.35546875
▁could 2.041015625
▁be 2.6796875
▁problem 2.6796875
atic 0.0011358261108398438
▁for 0.67724609375
▁women 1.4716796875
▁already 5.33203125
▁struggling 1.537109375
▁with 0.1322021484375
▁ob 1.15625
es 0.00135040283203125
ity 0.00010383129119873047
. 0.765625
▁Furthermore 3.271484375
, 0.0018520355224609375
▁studies 6.4765625
▁have 0.423583984375
▁suggested 2.279296875
▁a 2.642578125
▁potential 1.3466796875
▁link 2.341796875
▁between 0.0140838623046875
▁beta 3.259765625
- 0.034637451171875
block 0.018341064453125
ers 0.424072265625
▁and 0.056243896484375
▁an 2.837890625
▁increased 0.10302734375
▁risk 0.1058349609375
▁of 0.1072998046875
▁breast 0.619140625
▁cancer 0.027801513671875
. 0.91259765625
▁This 4.59765625
▁risk 3.119140625
▁is 1.2685546875
▁of 5.46875
▁particular 0.229736328125
▁concern 0.211181640625
▁for 0.6806640625
▁women 1.00390625
▁with 0.53759765625
▁a 1.1708984375
▁pre 0.344482421875
dis 0.007843017578125
position 0.00310516357421875
▁to 0.2291259765625
▁breast 0.20556640625
▁cancer 0.02471923828125
. 1.4814453125
<0x0A> 0.7255859375
On 2.91796875
▁the 0.1015625
▁other 0.144775390625
▁hand 0.0478515625
, 0.0098876953125
▁Nor 1.515625
vas 0.0021724700927734375
c 0.0014667510986328125
' 1.9521484375
s 0.15234375
▁potential 4.4296875
▁benefits 2.859375
▁include 1.2822265625
▁dil 3.787109375
ating 0.1077880859375
▁blood 0.1820068359375
▁vessels 0.0167999267578125
, 0.68115234375
▁which 1.1513671875
▁could 1.75390625
▁contribute 4.39453125
▁to 0.02191162109375
▁man 6.51171875
aging 0.0013303756713867188
▁blood 3.57421875
▁pressure 0.072021484375
▁and 1.1103515625
▁card 3.291015625
i 0.1776123046875
ov 0.0007762908935546875
asc 0.0003409385681152344
ular 1.800060272216797e-05
▁health 2.65234375
, 3.640625
▁especially 2.388671875
▁in 0.436279296875
▁ob 3.224609375
ese 0.1396484375
▁individuals 0.9697265625
. 1.0517578125
▁However 2.21875
, 0.0015287399291992188
▁Nor 1.9814453125
vas 0.0010328292846679688
c 0.00040221214294433594
▁has 1.9892578125
▁been 0.426513671875
▁associated 0.247802734375
▁with 0.0033664703369140625
▁peri 6.71484375
pher 0.0384521484375
al 0.00374603271484375
▁ed 1.0556640625
ema 0.01345062255859375
, 0.57421875
▁or 4.0
▁sw 0.86376953125
elling 0.003490447998046875
, 1.59765625
▁as 3.9296875
▁a 2.03125
▁common 4.53515625
▁side 0.385498046875
▁effect 0.0180511474609375
. 0.349609375
▁This 2.943359375
▁may 2.109375
▁not 4.39453125
▁be 0.2076416015625
▁ideal 4.4296875
▁for 0.2186279296875
▁women 0.7626953125
▁with 0.7578125
▁ob 1.0009765625
es 0.00974273681640625
ity 0.00039696693420410156
▁as 4.76171875
▁it 2.958984375
▁can 2.42578125
▁ex 4.48828125
ac 0.028594970703125
erb 0.0005331039428710938
ate 0.00255584716796875
▁the 1.431640625
▁dis 6.85546875
com 0.177978515625
fort 0.00019252300262451172
▁already 5.40234375
▁experienced 1.580078125
. 1.654296875
▁Nevertheless 5.55859375
, 0.001705169677734375
▁Nor 2.83984375
vas 0.0004887580871582031
c 0.0019397735595703125
▁is 1.4814453125
▁not 3.767578125
▁linked 5.98046875
▁to 0.242431640625
▁an 1.8681640625
▁increased 0.076171875
▁risk 0.049530029296875
▁of 0.033050537109375
▁breast 0.9677734375
▁cancer 0.02557373046875
, 1.529296875
▁which 2.548828125
▁is 1.7841796875
▁positive 7.25390625
▁for 1.1865234375
▁those 3.181640625
▁with 1.2470703125
▁a 0.95458984375
▁pre 0.10418701171875
dis 0.00585174560546875
position 0.005054473876953125
▁to 0.205322265625
▁the 2.119140625
▁disease 0.5830078125
. 0.16650390625
<0x0A> 0.418701171875
Cons 5.98046875
ider 0.146484375
ing 0.5068359375
▁di 6.4296875
et 0.568359375
▁and 1.4404296875
▁sm 0.2362060546875
oking 0.005092620849609375
▁in 2.890625
▁this 1.970703125
▁treatment 5.3359375
▁plan 2.947265625
▁is 3.322265625
▁essential 4.70703125
▁for 0.9990234375
▁optim 5.03515625
izing 0.04736328125
▁health 4.0546875
▁out 1.8173828125
comes 0.0009851455688476562
. 1.4091796875
▁Ob 5.41796875
es 0.1695556640625
ity 0.016265869140625
▁is 1.435546875
▁a 0.94580078125
▁known 4.22265625
▁risk 0.75048828125
▁factor 0.09881591796875
▁for 0.205078125
▁card 3.38671875
i 0.172607421875
ov 0.033416748046875
asc 0.001132965087890625
ular 0.0013580322265625
▁disease 0.80859375
, 0.619140625
▁and 1.458984375
▁a 2.359375
▁health 7.375
y 0.2117919921875
▁di 0.54443359375
et 0.003582000732421875
▁can 1.2568359375
▁play 3.876953125
▁a 0.310791015625
▁cru 2.552734375
cial 0.00133514404296875
▁role 0.04052734375
▁in 0.11468505859375
▁weight 6.9375
▁management 0.64306640625
▁and 2.02734375
▁reducing 2.91015625
▁card 1.89453125
i 0.06536865234375
ov 0.01023101806640625
asc 0.00018525123596191406
ular 0.0001417398452758789
▁ris 1.83984375
ks 0.0010976791381835938
. 0.1654052734375
▁Enc 10.1328125
ou 0.056488037109375
rag 0.0130157470703125
ing 0.135498046875
▁a 2.23828125
▁bal 3.025390625
anced 0.0003848075866699219
▁di 0.5537109375
et 0.0010013580322265625
, 2.140625
▁rich 7.63671875
▁in 0.0198822021484375
▁f 1.361328125
ruits 0.01384735107421875
, 1.720703125
▁veget 0.06585693359375
ables 0.0038127899169921875
, 0.188720703125
▁whole 2.119140625
▁gra 0.027313232421875
ins 0.0077667236328125
, 0.0963134765625
▁and 0.3671875
▁lean 1.6630859375
▁protein 0.91162109375
, 0.431640625
▁while 4.66796875
▁limit 2.666015625
ing 0.00011813640594482422
▁processed 3.337890625
▁food 0.249755859375
s 0.371337890625
, 0.90625
▁added 5.87890625
▁sug 0.2734375
ars 0.005138397216796875
, 0.061920166015625
▁and 0.327880859375
▁un 3.54296875
he 0.0180206298828125
alth 6.079673767089844e-05
y 0.014678955078125
▁f 1.7919921875
ats 0.0137939453125
, 0.6396484375
▁is 1.5224609375
▁necessary 3.666015625
▁for 0.89697265625
▁overall 4.63671875
▁health 0.97119140625
▁improvement 4.625
. 0.337158203125
<0x0A> 0.943359375
In 3.126953125
▁the 2.78125
▁case 2.798828125
▁of 0.034027099609375
▁Met 3.076171875
op 0.39697265625
rol 0.0220794677734375
ol 4.5078125
, 1.1865234375
▁di 4.546875
et 0.78466796875
ary 1.0068359375
▁consider 3.525390625
ations 0.0002130270004272461
▁are 1.54296875
▁cru 2.013671875
cial 0.006702423095703125
▁due 6.91015625
▁to 0.007419586181640625
▁the 0.5712890625
▁potential 0.73974609375
▁for 1.7119140625
▁weight 3.36328125
▁gain 0.455810546875
. 1.7216796875
▁Coun 9.5078125
sel 0.069580078125
ing 0.04986572265625
▁patients 2.146484375
▁about 2.134765625
▁maintain 4.421875
ing 0.00041961669921875
▁a 0.3349609375
▁health 0.45947265625
y 0.0399169921875
▁di 1.1826171875
et 0.0017309188842773438
▁and 1.3798828125
▁ens 5.87109375
uring 0.0009469985961914062
▁they 3.365234375
▁understand 6.08203125
▁potential 3.0859375
▁weight 5.171875
▁fl 4.55859375
uct 0.0002472400665283203
u 0.0010938644409179688
ations 0.0362548828125
▁associated 3.853515625
▁with 0.00508880615234375
▁the 1.5703125
▁medic 1.423828125
ation 0.146728515625
▁can 2.609375
▁help 1.6044921875
▁manage 3.654296875
▁any 5.03125
▁ad 3.423828125
verse 0.0004591941833496094
▁effects 0.89501953125
. 0.7138671875
▁Furthermore 2.82421875
, 0.003444671630859375
▁coun 3.80078125
sel 0.0199737548828125
ing 0.0292510986328125
▁on 4.3671875
▁sm 1.5078125
oking 0.0011749267578125
▁c 1.251953125
ess 0.0017843246459960938
ation 0.0032176971435546875
▁is 1.197265625
▁param 5.765625
ount 0.0002980232238769531
, 2.095703125
▁as 0.52197265625
▁sm 3.0546875
oking 0.17236328125
▁is 1.4375
▁associated 1.927734375
▁with 0.005428314208984375
▁an 1.6416015625
▁increased 0.04248046875
▁risk 0.052886962890625
▁of 0.09381103515625
▁card 1.462890625
i 0.07861328125
ov 0.00870513916015625
asc 9.846687316894531e-05
ular 0.00044083595275878906
▁disease 0.33837890625
▁and 1.75
▁breast 2.900390625
▁cancer 0.0209197998046875
. 0.391845703125
▁Com 6.90625
bin 1.2744140625
ing 0.049957275390625
▁the 2.11328125
▁use 3.326171875
▁of 0.0080108642578125
▁Met 1.3857421875
op 0.0206146240234375
rol 0.0010347366333007812
ol 0.0274810791015625
▁with 0.36181640625
▁sm 5.12890625
oking 0.0097198486328125
▁c 0.279052734375
ess 0.0007395744323730469
ation 0.039581298828125
▁inter 6.9296875
vent 0.060699462890625
ions 0.00030994415283203125
▁can 1.1640625
▁provide 4.13671875
▁a 1.705078125
▁compreh 3.552734375
ensive 0.0002503395080566406
▁approach 1.1279296875
▁to 0.421630859375
▁patient 5.4921875
▁care 1.615234375
. 0.498779296875
<0x0A> 0.343017578125
For 4.98828125
▁those 2.736328125
▁treated 5.91796875
▁with 0.5087890625
▁Nor 4.0234375
vas 0.00628662109375
c 0.00853729248046875
, 0.2127685546875
▁di 1.6923828125
et 0.049957275390625
ary 0.07568359375
▁recommend 2.888671875
ations 0.000522613525390625
▁should 2.7890625
▁pre 10.2265625
domin 0.93017578125
antly 0.06011962890625
▁focus 0.64794921875
▁on 0.01268768310546875
▁the 3.505859375
▁management 1.99609375
▁of 0.0164794921875
▁ob 1.1533203125
es 0.0115966796875
ity 0.00032782554626464844
▁and 0.62158203125
▁card 1.9111328125
i 0.033203125
ov 0.00897216796875
asc 0.00014352798461914062
ular 0.0011157989501953125
▁health 1.7978515625
. 0.483154296875
▁Sm 6.14453125
oking 0.06878662109375
▁c 0.8115234375
ess 0.0031147003173828125
ation 0.01849365234375
▁advice 7.296875
▁should 0.99072265625
▁still 7.58984375
▁be 0.06304931640625
▁provided 1.6025390625
, 1.09765625
▁but 2.427734375
▁with 3.296875
▁the 1.365234375
▁absence 9.8984375
▁of 0.004352569580078125
▁Met 3.791015625
op 0.00928497314453125
rol 0.0007205009460449219
ol 0.006305694580078125
, 0.60693359375
▁the 2.1171875
▁potential 2.12109375
▁interactions 8.7109375
▁between 0.908203125
▁medic 2.38671875
ation 2.150390625
▁and 0.239501953125
▁sm 1.8017578125
oking 0.003765106201171875
▁are 1.9931640625
▁mit 5.171875
ig 0.0001049041748046875
ated 0.00797271728515625
. 0.1669921875
<0x0A> 1.685546875
In 2.4375
▁conclusion 4.9296875
, 0.01334381103515625
▁the 2.421875
▁choice 6.75
▁between 0.97021484375
▁Met 0.326416015625
op 0.051177978515625
rol 0.002010345458984375
ol 0.07171630859375
▁and 0.1395263671875
▁Nor 0.06494140625
vas 0.0008387565612792969
c 0.0005421638488769531
▁for 1.388671875
▁tre 0.73681640625
ating 0.0005483627319335938
▁the 0.8681640625
▁sympt 0.08721923828125
oms 0.10235595703125
▁of 0.083251953125
▁prem 0.28564453125
ature 0.042816162109375
▁men 0.2061767578125
op 0.0088348388671875
ause 0.007305145263671875
▁in 2.98828125
▁middle 1.201171875
- 0.2489013671875
aged 0.004642486572265625
▁women 0.07684326171875
▁with 0.88720703125
▁ob 0.67724609375
es 0.00827789306640625
ity 0.0006351470947265625
▁and 0.63232421875
▁a 0.2303466796875
▁pre 0.0292205810546875
dis 0.00121307373046875
position 0.00231170654296875
▁to 0.285888671875
▁breast 0.2491455078125
▁cancer 0.007904052734375
▁requires 5.62109375
▁careful 2.6796875
▁consideration 0.283935546875
▁of 1.619140625
▁potential 1.2119140625
▁ris 0.94091796875
ks 0.0005345344543457031
▁and 0.165283203125
▁benefits 0.112060546875
. 0.283935546875
▁It 5.12890625
▁is 0.373779296875
▁essential 3.921875
▁to 0.230712890625
▁assess 3.80859375
▁the 0.445556640625
▁impact 4.96875
▁of 0.1541748046875
▁each 2.580078125
▁medic 0.328857421875
ation 0.007625579833984375
▁on 0.79736328125
▁card 2.84375
i 0.061431884765625
ov 0.0025463104248046875
asc 0.0003151893615722656
ular 0.0005512237548828125
▁health 0.62353515625
, 0.81787109375
▁weight 5.83984375
▁management 0.8486328125
, 0.050048828125
▁and 0.0843505859375
▁breast 2.318359375
▁cancer 0.07666015625
▁risk 1.3935546875
. 0.58984375
▁Moreover 5.37890625
, 0.0012388229370117188
▁a 3.642578125
▁compreh 3.8515625
ensive 0.007633209228515625
▁treatment 1.0771484375
▁plan 0.1656494140625
▁should 1.3857421875
▁include 1.4365234375
▁di 2.3203125
et 0.031341552734375
ary 0.1700439453125
▁recommend 1.4189453125
ations 0.0019550323486328125
▁and 1.80078125
▁sm 1.1865234375
oking 0.00014829635620117188
▁c 0.0256500244140625
ess 0.0001423358917236328
ation 0.0084686279296875
▁support 5.08203125
▁to 2.912109375
▁optimize 2.29296875
▁overall 2.6328125
▁health 0.818359375
▁out 0.90234375
comes 0.000835418701171875
. 0.1451416015625
▁Coll 10.4375
abor 0.0479736328125
ative 1.525390625
▁decision 5.21484375
- 0.4296875
making 0.002971649169921875
▁involving 5.07421875
▁patients 2.716796875
, 1.1376953125
▁health 3.037109375
care 0.6396484375
▁prov 0.4345703125
iders 0.003406524658203125
, 0.039825439453125
▁and 0.1177978515625
▁special 6.09375
ists 0.1141357421875
▁is 1.302734375
▁cru 2.19140625
cial 0.0019369125366210938
▁in 1.7578125
▁tail 6.31640625
oring 0.01947021484375
▁the 2.232421875
▁treatment 0.67919921875
▁plan 0.2734375
▁to 1.0888671875
▁the 1.3984375
▁individual 1.810546875
▁needs 1.8623046875
▁of 0.484375
▁each 1.361328125
▁patient 0.43701171875
, 2.810546875
▁maxim 9.21875
izing 0.0152130126953125
▁benefits 4.21875
▁while 1.4423828125
▁minim 0.71923828125
izing 0.0009250640869140625
▁ris 0.6728515625
ks 0.00029969215393066406
. 0.1693115234375
